Blog

Dec 10, 2023

A New Biomarker for Response to Checkpoint Inhibitors

Posted by in category: biotech/medical

Mismatch repair deficiency is a biomarker for predicting response to cancer immune checkpoint inhibitors. A new study may explain why it can fall short.

Leave a reply